Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy
Figure 3
Survival curves of patients with differentiated and poorly differentiated carcinomas. MST and 5-year survival rate were 25.9 months and 24.6% in patients with differentiated carcinoma, but those in patients with poorly differentiated carcinoma were 10.7 months and 0% (, ).
